| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |